Immunovant (4YB) Q2 2026 Earnings Report
DE:4YB Q2 2026 EPS Results
- Actual EPS
- -EUR 0.65
- Consensus EPS
- -EUR 0.64
- Beat/Miss
- Missed by -EUR 0.01
- One Year Ago EPS
- -EUR 0.66
DE:4YB Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 11/10/2025
- Time
- Before Open
- Conference Call
- Monday, November 10, 2025
DE:4YB Upcoming Earnings
Immunovant's next earnings date is estimated for November 9, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:4YB Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4YB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 09, 2026 | 2027 (Q2) | -0.66- | -0.65 | ― | ― |
| Aug 06, 2026 | 2027 (Q1) | -0.56-0.67 | -0.63 | -5.63% (-0.04) | |
| May 20, 2026 | 2026 (Q4) | -0.53-0.65 | -0.57 | -14.06% (-0.08) | |
| Feb 06, 2026 | 2026 (Q3) | -0.64-0.54 | -0.68 | 19.74% (+0.13) | |
| Nov 10, 2025 | 2026 (Q2) | -0.64-0.65 | -0.66 | 1.35% (+0.01) | |
| Aug 11, 2025 | 2026 (Q1) | -0.61-0.63 | -0.54 | -18.33% (-0.10) | |
| May 29, 2025 | 2025 (Q4) | -0.64-0.57 | -0.46 | -23.08% (-0.11) | |
| Feb 06, 2025 | 2025 (Q3) | -0.67-0.68 | -0.26 | -162.98% (-0.42) | |
| Nov 07, 2024 | 2025 (Q2) | -0.54-0.66 | -0.4 | -64.44% (-0.26) | |
| Aug 06, 2024 | 2025 (Q1) | -0.47-0.54 | -0.51 | -5.26% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed